Title:
COMBINATION OF SUBSTITUTED PYRIDINE COMPOUND AND ANOTHER MEDICINE
Document Type and Number:
WIPO Patent Application WO/2015/060422
Kind Code:
A1
Abstract:
The present invention provides a pharmaceutical composition for the treatment or prevention of diseases. The present invention provides a pharmaceutical composition which is characterized by being administered by combining a specific substituted pyridine compound or a salt thereof and another medicine.
Inventors:
TERASAKA NAOKI (JP)
Application Number:
PCT/JP2014/078324
Publication Date:
April 30, 2015
Filing Date:
October 24, 2014
Export Citation:
Assignee:
DAIICHI SANKYO CO LTD (JP)
UBE INDUSTRIES (JP)
UBE INDUSTRIES (JP)
International Classes:
A61K31/506; A61K31/40; A61K45/00; A61P3/06; A61P9/00; A61P9/10; A61P43/00
Domestic Patent References:
| WO2013103150A1 | 2013-07-11 | |||
| WO2012005343A1 | 2012-01-12 |
Other References:
M. JOHN CHAPMAN ET AL.: "Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors", EUROPEAN HEART JOURNAL, vol. 31, 2010, pages 149 - 164
Attorney, Agent or Firm:
ISHIBASHI Koki et al. (JP)
Kimiki Ishibashi (JP)
Kimiki Ishibashi (JP)
Download PDF: